AK6 and cancer: In humans, AK6 is known to be highly expressed in cancer and correlates with poor prognosis, and genome-wide polysome profiling has shown that hCINAP selectively regulates cancer-associated translatomes and promotes malignant transformation, making it a potential target for cancer therapy [82].